The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline
I Frost, H Sati, P Garcia-Vello… - The Lancet …, 2023 - thelancet.com
Vaccines can be highly effective tools in combating antimicrobial resistance as they reduce
infections caused by antibiotic-resistant bacteria and antibiotic consumption associated with …
infections caused by antibiotic-resistant bacteria and antibiotic consumption associated with …
Targeting inflammation and immunosenescence to improve vaccine responses in the elderly
B Pereira, XN Xu, AN Akbar - Frontiers in immunology, 2020 - frontiersin.org
One of the most appreciated consequences of immunosenescence is an impaired response
to vaccines with advanced age. While most studies report impaired antibody responses in …
to vaccines with advanced age. While most studies report impaired antibody responses in …
Impact of the coronavirus disease 2019 (COVID-19) pandemic on invasive pneumococcal disease and risk of pneumococcal coinfection with severe acute respiratory …
Z Amin-Chowdhury, F Aiano, A Mensah… - Clinical infectious …, 2021 - academic.oup.com
Background Streptococcus pneumoniae coinfection with influenza results in synergistic
lethality, but there are limited data on pneumococcal coinfection with severe acute …
lethality, but there are limited data on pneumococcal coinfection with severe acute …
[HTML][HTML] Serotype replacement after introduction of 10-valent and 13-valent pneumococcal conjugate vaccines in 10 countries, Europe
G Hanquet, P Krizova, T Dalby… - Emerging infectious …, 2022 - ncbi.nlm.nih.gov
We evaluated invasive pneumococcal disease (IPD) during 8 years of infant pneumococcal
conjugate vaccine (PCV) programs using 10-valent (PCV10) and 13-valent (PCV13) …
conjugate vaccine (PCV) programs using 10-valent (PCV10) and 13-valent (PCV13) …
Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an …
Background Invasive pneumococcal disease remains an important health priority owing to
increasing disease incidence caused by pneumococci expressing non-vaccine serotypes …
increasing disease incidence caused by pneumococci expressing non-vaccine serotypes …
Update on Streptococcus suis Research and Prevention in the Era of Antimicrobial Restriction: 4th International Workshop on S. suis
Streptococcus suis is a swine pathogen and a zoonotic agent afflicting people in close
contact with infected pigs or pork meat. Sporadic cases of human infections have been …
contact with infected pigs or pork meat. Sporadic cases of human infections have been …
The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus
S Simon, O Joean, T Welte… - European Respiratory …, 2023 - Eur Respiratory Soc
Exacerbations of COPD are associated with worsening of the airflow obstruction,
hospitalisation, reduced quality of life, disease progression and death. At least 70% of …
hospitalisation, reduced quality of life, disease progression and death. At least 70% of …
International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impact
Background Pneumococcal conjugate vaccines have reduced the incidence of invasive
pneumococcal disease, caused by vaccine serotypes, but non-vaccine-serotypes remain a …
pneumococcal disease, caused by vaccine serotypes, but non-vaccine-serotypes remain a …
Emerging vaccine strategies against the incessant pneumococcal disease
The incidence of invasive pneumococcal disease (IPD) caused by infection with the
pathogen Streptococcus pneumoniae (Spn) has been on a downward trend for decades due …
pathogen Streptococcus pneumoniae (Spn) has been on a downward trend for decades due …